The pseudo-hypoxic metabolism of clear cell renal cancer is based on a loss of VHL function, which induces stabilization and upregulation of hypoxia-associated gene products like HIF1A and VEGF (29). The gene discussed is VHL; the disease is clear cell renal carcinoma.